AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Virtue Insight invites you to the 9th Biosimilars Congregation 2016, 22nd Sept 2016, The Lalit Hotel, Mumbai, India

 CONFERENCE  Comments Off on Virtue Insight invites you to the 9th Biosimilars Congregation 2016, 22nd Sept 2016, The Lalit Hotel, Mumbai, India
Jul 132016
 

STR1

9th Biosimilars Congregation 2016 during 22nd September 2016 Mumbai,  INDIA

22nd September 2016, The Lalit Hotel, Mumbai, India

Link http://www.virtueinsight.com/pharma/9th-Biosimilars-Congregation-2016/

ANINDITA DAS

ANINDITA DAS

Dr. Reddy’s Laboratories

MANISH VERMA

MANISH VERMA

Sanofi

DEBOLINA PARTAP

DEBOLINA PARTAP

Wockhardt

PARIKSHIT CHAUDHARI

PARIKSHIT CHAUDHARI

Nestle

HANMANT BARKATE

HANMANT BARKATE

Intas Pharmaceuticals

CONFERENCE INTRODUCTION:-

Virtue Insight invites you to the 9th Biosimilars Congregation 2016 during 22nd September 2016 Mumbai – India. This 9th Biosimilars Congregation 2016 brings together scientists, researchers and CROs from around the world. Biologics are a highly effective class of medicines that are based on naturally occurring proteins and produced using living cells. Current concepts of drugs and biologics, Unique considerations for biologics, Early clinical development essentials, Cancer therapeutics, Comparability for Biologics, Biosimilar approvals are the points of discussion in this session.

9th Biosimilars Congregation 2016 conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Hence, this global event will look at the multiple facets of biosimilars, ranging from the evolving regulatory landscapes, biosimilar guidelines to the legal and economic aspects and current challenges in biosimilar development. This biosimilar conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place. By attending this biologics conference you will gain a comprehensive outlook on the key issues surrounding biosimilars. This event will provide an important platform for biosimilars stakeholders to discuss and share best practices in expediting development in Biosimilars 2016 and onwards.

 

KEY THEMES DISCUSSED IN THIS CONFERENCE:-

  • Global biopharma policy & market trends
  • The future of biosimilars in India
  • The evolving biosimilar sector: Trends and Implications
  • Complex biological models in biosimilar development
  • Viable extrapolation strategies for biosimilars with special emphasis on TNF antagonists
  • Effectively communicate the value of biosimilar products to raise confidence in the class
  • Improving characterization of biosimilars with technology
  • Create a robust patient services and reimbursement support program for biosimilar products
  • The future of the biosimilar industry – mapping the evolution and development of the biosimilar sector
  • Forecasting the financial growth of biosimilars in the global healthcare marketplace
  • Planning of a biosimilar development project – what to consider from the very beginning
  • Clinical development strategies for biosimilars
  • Gaining Better Market Access: Is Commercial CMO Acceptable for the Biosimilars Market?
  • Regulatory Updates and Development
  • Be part of a major networking opportunity

 

WHO WILL YOU MEET:-

CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:

  • Biopharmaceuticals/ Biotherapeutics
  • Follow on Biologics/Follow on Proteins
  • Biologics/Biotechnology/ Biogenerics
  • Legal Affairs
  • Intellectual Property
  • Health Economics
  • Pricing and Reimbursement
  • Clinical Immunology
  • Principal Scientist
  • Chief Scientific Officer
  • Process Control and Analytical Technologies
  • Analytical Characterisation
  • Regulatory Compliance
  • Pharmacovigilance
  • Drug Safety & Risk Management
  • Quality Affairs/ Quality Control
  • New Product Development
  • Process Science
  • Portfolio Management
  • Research & Development
  • Business Development
  • Business Operations
  • Scientific Affairs
  • Commercial Affairs

 

WHY SHOULD YOU ATTEND?

Get more from the event, with a broader scope bringing the whole communications value chain together? Enjoy and make the best out of ourdedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition.Expand your knowledge of the latest business models and strategies in the high-level conference. Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway. Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margin

Fen Castro

Fen Castro

Head – Productions

Virtue Insight

Tel (India) –       + 91 44 64614333

Mobile (India) –  + 91 9003 26 0693

Tel (UK) –          + 44 2036120886

Fen Castro fen@virtuefirms.com
Cc: Siddhaarth siddhaarth@virtueinsight.co.in

Link http://www.virtueinsight.com/pharma/9th-Biosimilars-Congregation-2016/

 

//////

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: